ATE270294T1 - 1,2,3,4-tetrahydro-benzofuro(3,2-c)pyridin derivate - Google Patents

1,2,3,4-tetrahydro-benzofuro(3,2-c)pyridin derivate

Info

Publication number
ATE270294T1
ATE270294T1 AT98921458T AT98921458T ATE270294T1 AT E270294 T1 ATE270294 T1 AT E270294T1 AT 98921458 T AT98921458 T AT 98921458T AT 98921458 T AT98921458 T AT 98921458T AT E270294 T1 ATE270294 T1 AT E270294T1
Authority
AT
Austria
Prior art keywords
benzofuro
tetrahydro
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
AT98921458T
Other languages
English (en)
Inventor
Ludo Edmond Josephine Kennis
Christopher John Love
Francois Paul Bischoff
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE270294T1 publication Critical patent/ATE270294T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT98921458T 1997-04-08 1998-04-02 1,2,3,4-tetrahydro-benzofuro(3,2-c)pyridin derivate ATE270294T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201045 1997-04-08
PCT/EP1998/002136 WO1998045297A1 (en) 1997-04-08 1998-04-02 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES__

Publications (1)

Publication Number Publication Date
ATE270294T1 true ATE270294T1 (de) 2004-07-15

Family

ID=8228191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921458T ATE270294T1 (de) 1997-04-08 1998-04-02 1,2,3,4-tetrahydro-benzofuro(3,2-c)pyridin derivate

Country Status (31)

Country Link
US (1) US6156757A (de)
EP (1) EP1019408B1 (de)
JP (1) JP3287577B2 (de)
KR (1) KR100315975B1 (de)
CN (1) CN1097053C (de)
AP (1) AP1138A (de)
AR (1) AR012576A1 (de)
AT (1) ATE270294T1 (de)
AU (1) AU727599B2 (de)
BG (1) BG63848B1 (de)
BR (1) BR9806263A (de)
CA (1) CA2264598C (de)
CZ (1) CZ290008B6 (de)
DE (1) DE69824872T2 (de)
EE (1) EE03691B1 (de)
ES (1) ES2224391T3 (de)
GE (1) GEP20022823B (de)
HU (1) HUP0003624A3 (de)
ID (1) ID22131A (de)
IL (1) IL128701A0 (de)
MY (1) MY120033A (de)
NO (1) NO322826B1 (de)
NZ (1) NZ334501A (de)
PL (1) PL189549B1 (de)
RU (1) RU2198175C2 (de)
SK (1) SK283621B6 (de)
TR (1) TR199900644T2 (de)
TW (1) TW589315B (de)
UA (1) UA52681C2 (de)
WO (1) WO1998045297A1 (de)
ZA (1) ZA982969B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
ID28451A (id) * 1998-10-06 2001-05-24 Janssen Pharmaceutica Nv Trisiklik piperidin-δ3 sebagai bahan farmasi
UA70334C2 (en) 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
AU765751B2 (en) * 1998-12-21 2003-09-25 Janssen Pharmaceutica N.V. Benzisoxazoles and phenones as alpha2-antagonists
EP1404679A2 (de) 2001-07-05 2004-04-07 PHARMACIA & UPJOHN COMPANY (hetero)aryl substituierte benzofuranen als 5-ht liganden
ATE521593T1 (de) * 2002-04-03 2011-09-15 Orion Corp Verwendung eines alfa2-adrenorezeptorantagonisten bei mit dem zns zusammenhängenden erkrankungen
JP4690043B2 (ja) * 2002-10-04 2011-06-01 プラナ バイオテクノロジー リミティッド 神経に対し活性な化合物
WO2005100355A1 (ja) 2004-04-12 2005-10-27 Taisho Pharmaceutical Co., Ltd. 環状アミン化合物
RU2409582C2 (ru) * 2004-08-31 2011-01-20 Глэксо Груп Лимитед Конденсированные трициклические производные для лечения психотических расстройств
EP2535330A3 (de) * 2006-10-23 2012-12-26 Takeda Pharmaceutical Company Limited Iminopyridinderivate und deren Verwendung
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
AR071392A1 (es) * 2008-04-23 2010-06-16 Takeda Pharmaceutical Derivados de iminopiridina y su uso
US8575186B2 (en) * 2009-10-05 2013-11-05 Albany Molecular Research, Inc. Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
EP2668191A4 (de) 2011-01-19 2014-08-20 Albany Molecular Res Inc Benzofuro-[3,2-c-]pyridine und verwandte analoga als serotonin-untertyp-6 (5-ht6)-modulatoren zur behandlung von adipositas, stoffwechselsyndrom, kognition und schizophrenie
GB201704325D0 (en) * 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4688803A (en) * 1984-06-25 1987-08-25 Ollington Robert F Casino game table and dice
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
RU2045529C1 (ru) * 1988-04-26 1995-10-10 Ниссан Кемикал Индастриз Лтд. Способ получения мевалонолактоновых производных
US4985422A (en) * 1988-04-27 1991-01-15 Glaxo Group Limited Lactam derivatives
DE4308451A1 (de) * 1992-09-10 1994-04-14 Bayer Ag 3-Aryl-pyron-Derivate
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

Also Published As

Publication number Publication date
AP9901650A0 (en) 1999-09-30
TW589315B (en) 2004-06-01
SK28799A3 (en) 2001-03-12
BG103213A (en) 2000-05-31
CZ68299A3 (cs) 2000-08-16
ID22131A (id) 1999-09-09
CN1237179A (zh) 1999-12-01
UA52681C2 (uk) 2003-01-15
KR20000036076A (ko) 2000-06-26
HUP0003624A2 (hu) 2001-04-28
KR100315975B1 (ko) 2001-12-22
NO990859L (no) 1999-09-30
EP1019408B1 (de) 2004-06-30
DE69824872T2 (de) 2005-09-01
WO1998045297A1 (en) 1998-10-15
BG63848B1 (bg) 2003-03-31
ES2224391T3 (es) 2005-03-01
PL332382A1 (en) 1999-09-13
RU2198175C2 (ru) 2003-02-10
AU727599B2 (en) 2000-12-14
CA2264598A1 (en) 1998-10-15
TR199900644T2 (xx) 2000-09-21
CZ290008B6 (cs) 2002-05-15
GEP20022823B (en) 2002-10-25
SK283621B6 (sk) 2003-10-07
AU7430798A (en) 1998-10-30
EE03691B1 (et) 2002-04-15
JP2000505115A (ja) 2000-04-25
PL189549B1 (pl) 2005-08-31
DE69824872D1 (de) 2004-08-05
CA2264598C (en) 2006-10-24
HUP0003624A3 (en) 2002-09-30
JP3287577B2 (ja) 2002-06-04
IL128701A0 (en) 2000-01-31
NZ334501A (en) 2000-06-23
US6156757A (en) 2000-12-05
NO322826B1 (no) 2006-12-11
BR9806263A (pt) 2000-04-04
NO990859D0 (no) 1999-02-23
ZA982969B (en) 1999-10-07
MY120033A (en) 2005-08-30
EP1019408A1 (de) 2000-07-19
AR012576A1 (es) 2000-11-08
CN1097053C (zh) 2002-12-25
EE9900114A (et) 1999-12-15
AP1138A (en) 2003-01-17

Similar Documents

Publication Publication Date Title
DE69839398D1 (de) Pyridinderivate
NO994791L (no) Nikotinamid-derivater
DE69907964D1 (de) 1,2-annelierte chinolinderivate
DE69728676D1 (de) Substituierte 6,6-heterobicyclische derivate
DE69809755D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalin derivate
ATE293618T1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
ATE202105T1 (de) 8-substituierte-1,3,8-triazaspiro(4,5)decan-4- onderivate
DE69521645D1 (de) Pyridinderivate
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
ATE212635T1 (de) 1,3,8-triazaspiro(4,5)decan-4-on-derivate
ATE270294T1 (de) 1,2,3,4-tetrahydro-benzofuro(3,2-c)pyridin derivate
DE69502542D1 (de) 2-Phenyl-7-chlor-perhydroimidazo(1,5-a)pyridine
ATE204279T1 (de) Diaza-spiro(3,5)nonan-derivate
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
DE69724941D1 (de) Aminopyridin-derivate
DE69707293D1 (de) Pyrrolo(3,2-c)chinolin-derivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties